Advertisement
BWAY vs TCMD
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BWAY is a Buy and TCMD is a Buy.
BWAY's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for BWAY turned positive on October 19, 2026. Looking at past instances where BWAY's MACD turned positive, the stock continued to rise in 42 of 49 cases over the following month. The odds of a continued upward trend are 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BWAY's RSI Oscillator exited the oversold zone, 16 of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 41 of 57 cases where BWAY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
Following a +9.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where BWAY advanced for three days, in 219 of 261 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
BWAY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BWAY as a result. In 82 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BWAY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.
The Aroon Indicator for BWAY entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. BWAY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 62 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 68 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BWAY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 75 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 83 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.666) is normal, around the industry mean (4.142). P/E Ratio (44.600) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (8.681) is also within normal values, averaging (40.124).
Aroon Indicator for TCMD shows an upward move is likely
TCMD's Aroon Indicator triggered a bullish signal on November 02, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 234 similar instances where the Aroon Indicator showed a similar pattern. In 201 of the 234 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 86%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 14, 2026. You may want to consider a long position or call options on TCMD as a result. In 66 of 98 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 67%.
TCMD moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for TCMD crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 6 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.
Following a +2.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where TCMD advanced for three days, in 210 of 268 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
Bearish Trend Analysis
The 10-day RSI Indicator for TCMD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 25 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 62%.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TCMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
TCMD broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. TCMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.634) is normal, around the industry mean (4.142). P/E Ratio (23.881) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.290) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (1.458) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TCMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
BWAY | TCMD | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 15 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 83 Overvalued | 68 Overvalued | |
PROFIT vs RISK RATING 1..100 | 68 | 100 | |
SMR RATING 1..100 | 62 | 65 | |
PRICE GROWTH RATING 1..100 | 59 | 41 | |
P/E GROWTH RATING 1..100 | 75 | 78 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TCMD's Valuation (68) in the Medical Specialties industry is in the same range as BWAY (83). This means that TCMD’s stock grew similarly to BWAY’s over the last 12 months.
BWAY's Profit vs Risk Rating (68) in the Medical Specialties industry is in the same range as TCMD (100). This means that BWAY’s stock grew similarly to TCMD’s over the last 12 months.
BWAY's SMR Rating (62) in the Medical Specialties industry is in the same range as TCMD (65). This means that BWAY’s stock grew similarly to TCMD’s over the last 12 months.
TCMD's Price Growth Rating (41) in the Medical Specialties industry is in the same range as BWAY (59). This means that TCMD’s stock grew similarly to BWAY’s over the last 12 months.
BWAY's P/E Growth Rating (75) in the Medical Specialties industry is in the same range as TCMD (78). This means that BWAY’s stock grew similarly to TCMD’s over the last 12 months.
| BWAY | TCMD | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 80% | 2 days ago 63% |
| Stochastic ODDS (%) | 2 days ago 72% | 2 days ago 76% |
| Momentum ODDS (%) | 2 days ago 83% | 2 days ago 67% |
| MACD ODDS (%) | 2 days ago 86% | N/A |
| TrendWeek ODDS (%) | 2 days ago 80% | 2 days ago 83% |
| TrendMonth ODDS (%) | 2 days ago 77% | 2 days ago 85% |
| Advances ODDS (%) | 3 days ago 84% | 2 days ago 78% |
| Declines ODDS (%) | 10 days ago 77% | 6 days ago 75% |
| BollingerBands ODDS (%) | 2 days ago 80% | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 80% | 2 days ago 86% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BWAY’s FA Score shows that 0 FA rating(s) are green while TCMD’s FA Score has 0 green FA rating(s).
- BWAY’s FA Score: 0 green, 5 red.
- TCMD’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BWAY’s TA Score shows that 5 TA indicator(s) are bullish while TCMD’s TA Score has 5 bullish TA indicator(s).
- BWAY’s TA Score: 5 bullish, 3 bearish.
- TCMD’s TA Score: 5 bullish, 4 bearish.
Price Growth
BWAY (@Medical/Nursing Services) experienced а -4.30% price change this week, while TCMD (@Medical/Nursing Services) price change was +7.43% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.89%. For the same industry, the average monthly price growth was -4.69%, and the average quarterly price growth was -1.76%.
Reported Earning Dates
BWAY is expected to report earnings on Mar 17, 2027.
TCMD is expected to report earnings on Feb 23, 2027.
Industries' Descriptions
@Medical/Nursing Services (-2.89% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
BWAY and
Correlation & Price change
A.I.dvisor indicates that over the last year, BWAY has been loosely correlated with DCTH. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if BWAY jumps, then DCTH could also see price increases.
| Ticker / NAME | Correlation To BWAY | 1D Price Change % | ||
|---|---|---|---|---|
| BWAY | 100% | -8.33% | ||
| DCTH - BWAY | 34% Loosely correlated | -0.84% | ||
| MBOT - BWAY | 33% Poorly correlated | -4.55% | ||
| ISRG - BWAY | 31% Poorly correlated | -2.28% | ||
| TCMD - BWAY | 31% Poorly correlated | +0.11% | ||
| QSI - BWAY | 30% Poorly correlated | -6.57% | ||
More | ||||
TCMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with CSTL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then CSTL could also see price increases.
| Ticker / NAME | Correlation To TCMD | 1D Price Change % | ||
|---|---|---|---|---|
| TCMD | 100% | +0.11% | ||
| CSTL - TCMD | 50% Loosely correlated | +0.12% | ||
| UFPT - TCMD | 47% Loosely correlated | -1.51% | ||
| AORT - TCMD | 43% Loosely correlated | -0.82% | ||
| IRMD - TCMD | 39% Loosely correlated | -0.25% | ||
| ESTA - TCMD | 38% Loosely correlated | -1.88% | ||
More | ||||